Journal of Chemotherapy

Papers
(The TQCC of Journal of Chemotherapy is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Managing adult patients with infectious diseases in emergency departments: international ID-IRI study24
Comparison of lorlatinib, alectinib and brigatinib in ALK inhibitor–naive/untreated ALK-positive advanced non-small-cell lung cancer: a systematic review and network meta-analysis19
Activity of ceftolozane-tazobactam, ceftazidime-avibactam, meropenem-vaborbactam, cefiderocol and comparators against Gram-negative organisms causing bloodstream infections in Northern Italy (2019–20215
Infective endocarditis by Enterobacter cloacae: a systematic review and meta-analysis14
Luteolin suppresses lung cancer progression through targeting the circ_0000190/miR-130a-3p/notch-1 signaling pathway14
Evaluation of efficacy and safety of fosfomycin versus nitrofurantoin for the treatment of uncomplicated lower urinary tract infection (UTI) in women – A systematic review and meta-analysis12
CircRNA_001895 promotes sunitinib resistance of renal cell carcinoma through regulation of apoptosis and DNA damage repair12
Prognostic factors and effect on survival of immune-related adverse events in patients with non-small-cell lung cancer treated with immune checkpoint blockage11
Performance of capecitabine in novel combination therapies in colorectal cancer11
Anti-biofilm activity of dalbavancin against methicillin-resistant Staphylococcus aureus (MRSA) isolated from human bone infection11
Circ_0007841 knockdown confers cisplatin sensitivity to ovarian cancer cells by down-regulation of NFIB expression in a miR-532-5p-dependent manner10
Investigation of anticancer activities of STA-9090 (ganetespib) as a second generation HSP90 inhibitor in Saos-2 osteosarcoma cells10
MiR-144-3p inhibits the proliferation, migration and invasion of lung adenocargen cancer cells by targeting COL11A110
miR-302a-3p suppresses melanoma cell progression via targeting METTL310
A plethora of carbapenem resistance inAcinetobacter baumannii: no end to a long insidious genetic journey10
Therapeutic options for COVID-19: a quick review10
Urinary tract infection in a human male patient with Staphylococcus pseudintermedius transmission from the family dog10
Metformin induces myeloma cells necrosis and apoptosis and it is considered for therapeutic use10
Calcium-oxidative stress signaling axis and casein kinase 1α mediate eryptosis and hemolysis elicited by novel p53 agonist inauhzin9
Trabectedin-irinotecan, a potentially promising combination in relapsed desmoplastic small round cell tumor: report of two cases9
miR-4486 enhances cisplatin sensitivity of gastric cancer cells by restraining the JAK3/STAT3 signalling pathway9
FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer9
Early 3-day course of remdesivir in vaccinated outpatients with SARS-CoV-2 infection. A success story9
LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis9
Infective endocarditis byKlebsiellaspecies: a systematic review9
In-vitro activity of fosfomycin against Escherichia coli and Klebsiella pneumoniae bloodstream isolates and frequency of OXA-48, NDM, KPC, VIM, IMP types of carbapenemases 8
Current treatments for inoperable mesothelioma: indirect comparisons based on individual patient data reconstructed retrospectively from 4 trials8
Application of tumoroids derived from advanced colorectal cancer patients to predict individual response to chemotherapy8
Relationship between renal dysfunction and electrolyte abnormalities in hematopoietic stem cell transplant patients treated with foscarnet8
Knockdown of METTL5 inhibits the Myc pathway to downregulate PD-L1 expression and inhibits immune escape of hepatocellular carcinoma cells8
Voriconazole pharmacokinetics in a critically ill patient during extracorporeal membrane oxygenation8
C1q-like 1 is frequently up-regulated in lung adenocarcinoma and contributes to the proliferation and invasion of tumor cells8
Prognostic significance of sarcopenia and decreased relative dose intensity during the initial two cycles of first-line sunitinib for metastatic renal cell carcinoma8
Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center’s experience7
Infective endocarditis by Serratia species: a systematic review7
Natural substances to potentiate canonical glioblastoma chemotherapy7
Novel daidzein molecules exhibited anti-prostate cancer activity through nuclear receptor ERβ modulation, in vitro and in vivo studies7
Initial trough concentration may be beneficial in preventing linezolid-induced thrombocytopenia7
Effect of remdesivir on mortality rate and clinical status of COVID-19 patients: a systematic review with meta-analysis6
Proinflammatory circulating markers: new players for evaluating asymptomatic acute cardiovascular toxicity in breast cancer treatment6
Circ_SETD3 regulates gefitinib sensitivity and tumor progression by miR-873-5p-dependent regulation of APPBP2 in non-small cell lung cancer6
Infective endocarditis in patients with liver cirrhosis: a systematic review6
Activity of cefiderocol and synergy of novel β-lactam-β-lactamase inhibitor-based combinations against metallo-β-lactamase-producing gram-negative bacilli: insights from a two-year study (2019–2020)6
Capecitabine-associated enterocolitis: Narrative literature review of a rare adverse event and a case presentation6
Pediatric impetigo: an expert panel opinion about its main controversies6
Efficacy and safety of intravenous fosfomycin for the treatment of carbapenem-resistant Klebsiella pneumoniae6
LncRNA-IQCH-AS1 sensitizes thyroid cancer cells to doxorubicin via modulating the miR-196a-5p/PPP2R1B signalling pathway6
Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients6
Epidemiology, aetiology and treatment of skin and soft tissue infections: final report of a prospective multicentre national registry6
Lambert-Eaton myasthenic syndrome (LEMS) in a patient with lung cancer under treatment with pembrolizumab: a case study6
Mechanisms underlying dose-limiting toxicities of conventional chemotherapeutic agents6
Comparative incidence of acute kidney injury in patients on vancomycin therapy in combination with cefepime, piperacillin-tazobactam or meropenem5
The effect of PARP inhibitors in homologous recombination proficient ovarian cancer: meta-analysis5
The point prevalence and inappropriateness of antibiotic use at hospitals in Turkey: a systematic review and meta-analysis5
Dalbavancin treatment for spondylodiscitis: multi-center clinical experience and literature review5
Looking beyond ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae: in vitro activity of the novel meropenem-vaborbactam in combination with the old fosfomycin5
Effect of HDAC9 inhibition on epithelial-mesenchymal transition in CD133+ prostate cancer cell lines5
Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients5
Sorafenib for hepatocellular carcinoma: potential molecular targets and resistance mechanisms5
Risk of fatigue with PARP inhibitors in cancer patients: a systematic review and meta-analysis of 29 phase II/III randomized controlled trials5
Knockdown of microRNA-203 reduces cisplatin chemo-sensitivity to osteosarcoma cell lines MG63 and U2OS in vitro by targeting RUNX25
Anlotinib as a post-third-line therapy for the treatment of advanced nonsmall cell lung cancer5
Amoxicillin-associated Stevens-Johnson syndrome or toxic epidermal necrolysis: systematic review4
Pharmacodynamics of D-mannose in the prevention of recurrent urinary infections4
Recovery of borderline oxacillin-resistant Staphylococcus pseudintermedius (BORSP) from bone and soft tissue of a rheumatoid arthritis patient with severe osteoporosis: transmission from the fa4
Fosfomycin therapeutic drug monitoring in real-life: development and validation of a LC-MS/MS method on plasma samples4
Overexpression of long non-coding RNA urothelial carcinoma associated 1 causes paclitaxel (Taxol) resistance in colorectal cancer cells by promoting glycolysis4
MAP7 promotes proliferation and migration of breast cancer cells and reduces the sensitivity of breast cancer cells to paclitaxel4
Disseminated fusariosis in immunocompromised children: a case series and review of literature4
The tumor microenvironment: shaping cancer progression and treatment response4
Frizzled-3 suppression overcomes multidrug chemoresistance by Wnt/β-catenin signaling pathway inhibition in hepatocellular carcinoma cells4
Circ_0048856 competes with ABCC1 for miR-193a-5p/miR-98-5p binding sites to promote the cisplatin resistance and tumorigenesis in lung cancer4
Dalbavancin as chronic antibiotic suppression therapy for left ventricular assist device driveline infection due to methicillin-resistant Staphylococcus aureus: a case report4
Real life experience with ceftolozane/tazobactam therapy for Pseudomonas aeruginosa bacteremia4
Outcomes of diagnosed COVID-19 cancer patients: concerning results of a systematic review4
Optimization of dosing regimens of vancomycin, teicoplanin, linezolid and daptomycin against methicillin-resistant Staphylococcus aureus in neutropenic patients with cancer by Monte Carlo simul4
Pegylated liposomal doxorubicin as first line treatment in aids-related Kaposi’s sarcoma: a real-life study4
Vancomycin pharmacokinetics in patients treated with intermittent haemodialysis based on therapeutic drug monitoring4
Carbapenem-resistant Klebsiella pneumoniae outbreak in a COVID-19 intensive care unit; a case-control study4
Overcoming cisplatin resistance of human lung cancer by sinomenine through targeting the miR-200a-3p-GLS axis4
Bictegravir/emtricitabine/tenofovir alafenamide combination in the management of kidney transplant patients with HIV receiving immunosuppressants4
Risk of hypertension with anti-VEGF monoclonal antibodies in cancer patients: a systematic review and meta-analysis of 105 phase II/III randomized controlled trials4
Endocarditis in kidney transplant recipients: a systematic review4
Linezolid-related adverse effects in the treatment of rifampicin resistant tuberculosis: a retrospective study4
Relationship between pathological response and molecular subtypes in locally advanced breast cancer patients receiving neoadjuvant chemotherapy4
0.071903944015503